Adjusted EBITDA: $145 million, an improvement of $7 million over the prior year quarter. Adjusted EPS: $0.39, lower than the prior year due to a non-reoccurrence of a $48 million one-time tax benefit and $14 million higher interest expense. Adjusted Free Cash Flow: Net use of $62 million, slightly higher than the prior year due to higher interest expense. Polymers Volume Growth: Up 2.7%, driven by small containers and IPC demands. Integrated Solutions Volume Growth: Low double-digit growth in caps and enclosures, and paints linings and adhesives. Cost Optimization Savings: $5 million identified on a run rate basis, with expectations to achieve $15 million to $25 million by the end of fiscal 2025. Mill Closures Impact: Short-term EBITDA headwind of $3 million in fiscal '25, expected to be EBITDA positive by $8 million by 2027. 2025 Guidance: Low-end guidance raised to $710 million for fiscal '25. Free Cash Flow Guidance: Raised by $20 million to $245 million for the full year. Warning! GuruFocus has detected 5 Warning Sign with GEF. Release Date: February 27, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Greif Inc (NYSE:GEF) announced a $100 million cost optimization initiative, which is expected to enhance profitability. The company has identified $5 million in savings on a run rate basis and expects to achieve $15 million to $25 million by the end of fiscal 2025. Greif Inc (NYSE:GEF) is focusing on high-growth markets such as agrochemicals, food and beverage, and pharmaceuticals, which are expected to drive future growth. The company plans to sell its timberland portfolio to reduce debt, which will improve its financial flexibility. Despite a challenging industrial economy, Greif Inc (NYSE:GEF) reported an adjusted EBITDA of $145 million for the quarter, an improvement over the prior year. Negative Points The industrial economy remains uncertain, impacting demand in key sectors such as metals and bulk chemicals. Greif Inc (NYSE:GEF) is facing higher SG&A costs due to business reorganization and investments in long-term value creation. The closure of two facilities will result in a short-term EBITDA headwind of $3 million in fiscal 2025 due to closure costs. Adjusted free cash flow was a net use of $62 million, primarily due to higher interest expenses. North America continues to show the weakest demand sentiment compared to other regions, affecting overall performance. Q & A Highlights Q: Can you provide clarity on the first quarter results for the fiber segment, as it seemed below expectations despite price increases? A: Lawrence Hilsheimer, CFO, explained that the fiber segment performed in line with their expectations, slightly better even. The confusion arises from the allocation of SG&A costs, which are based on value add. As margins expand in the fiber business, it receives a larger portion of SG&A. This allocation method is consistent with their protocol, and while it may seem confusing, it is a standard practice. Story Continues Q: Could you elaborate on the regional performance differences, particularly why EMEA is more resilient compared to North America? A: Ole Rosgaard, CEO, noted that the difference is due to the end market exposure. EMEA has shown significant growth in agrochemical markets, which are GDP-plus growth markets. North America, on the other hand, is facing more challenges, but they continue to focus on growth in food and beverage, pharma, and agrochemical segments. Q: What are the expectations for SG&A margins moving forward, and how will they progress through the year? A: Lawrence Hilsheimer, CFO, stated that SG&A costs are expected to stabilize as the year progresses. The increase in SG&A was partly due to the integration of APAC Chem and reallocation of costs. As they move through the year, EBITDA margins are expected to improve steadily, benefiting from volume lifts and cost leverage. Q: Can you provide more details on the Timberland sale and its impact on the company's strategy? A: Ole Rosgaard, CEO, mentioned that the Timberland sale is part of their strategy to optimize the portfolio. The proceeds will be used to reduce debt, enhancing their financial flexibility. While they can't comment on timing or value, they are confident in the interest and value of the land. Q: What are the most promising end markets for Greif, and where do you see the most potential for growth? A: Ole Rosgaard, CEO, highlighted agrochemicals as a key growth area, especially after acquiring Reliance Lee and APAC Chem. Food and beverage, as well as pharma, are also promising markets. These segments are expected to drive growth due to their GDP-plus potential. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Greif Inc (GEF) Q1 2025 Earnings Call Highlights: Strategic Moves and Market Growth Amid ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...